PDE 5 inhibitors (Guangzhou Boji Medical & Biotechnological)

N/A

Report date: 2025/03/20 15:37:43
NME

Base Information

Drug NamePDE 5 inhibitors (Guangzhou Boji Medical & Biotechnological)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 5A inhibitors
TargetsPhosphodiesterase 5A
Therapy Area/IndicationsHypertension, Pulmonary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBoji Medical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBoji Medical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsHypertension, Pulmonary
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A